Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2012
10/17/2012CN102740888A Antibodies to IL-6 and use there
10/17/2012CN102740881A Method for orthopoxvirus production and purification
10/17/2012CN102740876A Treatment of pre-term neonates
10/17/2012CN102740875A Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
10/17/2012CN102740874A Methods and compositions for liquidation of tumors
10/17/2012CN102740873A Oxyntomodulin peptide analogue
10/17/2012CN102740872A Methods and compositions for providing protective immunity in the elderly
10/17/2012CN102740854A Loxoprofen-containing pharmaceutical composition
10/17/2012CN102740836A Method for the production of commercial nanoparticle and microparticle powders
10/17/2012CN102735843A JMJD8 gene and expression product for inhibiting growth of hepatoma cells
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732543A Tumor genetically-engineered vaccine utilizing mucin-1 and survivin as target sites
10/17/2012CN102732524A Use of histidine-rich glycoprotein (HRG)-like lampetra japonica Lj-RGD3 all RGD deletion mutant Lj-112 in antitumor drug
10/17/2012CN102732498A Application of protease tablysin to preparation of medicament for treating tumor
10/17/2012CN102731658A Tat PTD-Endostatin recombination protein, preparation method and application thereof
10/17/2012CN102731632A Recombinant ganoderma immunomodulatory protein monomethoxypolyglycol succinimidyl propionate modifier, preparation method and use thereof
10/17/2012CN102731630A Antioxidant oligopeptide with skin penetration capability
10/17/2012CN102731629A Antibacterial peptide and application thereof
10/17/2012CN102731626A Cyclopeptide and its medicinal application
10/17/2012CN102731405A Photodynamic treatment medicament, medical composition and preparation method thereof
10/17/2012CN102727929A Hemostat, preparation method thereof, and application thereof
10/17/2012CN102727899A Protein-medicament-carrying PLGA composite microspheres and preparation method thereof
10/17/2012CN102727893A Recombinant human endostatin liposome microbubble and application thereof in preparing medicament for inhibiting tumor angiogenesis under ultrasound mediation
10/17/2012CN102727874A Recombinant hirudin eye drops and preparation method thereof
10/17/2012CN102727873A Applications of buckwheat trypsin inhibitor
10/17/2012CN102727872A Anti-aging and heart and blood vessel protecting soft capsule and preparation method thereof
10/17/2012CN102727871A Scar-removing and skin beautifying Cordyceps sinensis composition and preparation method thereof
10/17/2012CN102727870A Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy
10/17/2012CN102727869A Application of soluble interleukin 6 receptor in antiviral medicine preparation
10/17/2012CN102727868A Anti-tumor drug composition and application thereof, kit and package
10/17/2012CN102727867A Antineoplastic pharmaceutical composition and application thereof, kit and package
10/17/2012CN102727866A Antibacterial peptide composition and preparation method thereof
10/17/2012CN102727865A Compound calcium capsule free of calcium carbonate and vitamin D
10/17/2012CN102727864A Novel application of polypeptide GluR2-3Y
10/17/2012CN102727863A Combined drug of compound fermented Cordyceps sinensis powder and ginsenoside Rg1
10/17/2012CN102727862A Delapril hydrochloride-Chuanxiong oil nanoemulsion antihypertensive drug
10/17/2012CN102727861A Treatment of t-cell mediated diseases
10/17/2012CN102727469A Dry powder inhalant of interferon alpha
10/17/2012CN102727468A Dry powder inhaler of interferon alpha
10/17/2012CN102727467A Dry powder inhalant of interferon alpha
10/17/2012CN102727437A Liposome treatment of viral infections
10/17/2012CN102727429A Pidotimod injection with modified stability, and preparation method thereof
10/17/2012CN102727428A Preparation method of muscular amino acids and nucleosides injection
10/17/2012CN102727420A D-glutamyl-D-tryptophan sodium colon targeting drug delivery agent and preparation method thereof
10/17/2012CN102286465B Pig IFITM3 gene for inhibiting mouth disease virus multiplication, and construction method and application
10/17/2012CN102166183B Immunologic stimulant oral syrup and preparation method thereof
10/17/2012CN102080098B Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation
10/17/2012CN102046166B Methods of treating dry eye
10/17/2012CN101972470B In-situ gel composition for eyes
10/17/2012CN101967195B Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof
10/17/2012CN101948507B Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof
10/17/2012CN101906149B Linear polypeptide and synthetic method and application thereof
10/17/2012CN101906138B Pseudo cyclic polypeptide and synthesis method and application thereof
10/17/2012CN101891812B Mechano growth factor polypeptide, preparation method and application thereof
10/17/2012CN101676297B Preparation method of sea cucumber active polypeptide under ultrasonic extraction
10/17/2012CN101497881B Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant
10/17/2012CN101466727B Hcv/hiv inhibitor and their uses
10/17/2012CN101406452B Ciclosporin A microemulsion formulation for injection and preparation method thereof
10/17/2012CN101400361B Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
10/17/2012CN101316608B Bacillus subtilis novel bacterial strain and usage thereof in preparation of medicament for treating thrombus disease
10/17/2012CN101247822B EPO derivative-containing therapeutic agents for blood-related diseases
10/16/2012US8288610 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/16/2012US8288512 Use of amphiphilic self-assembling proteins for formulating poorly water-soluble effect substances
10/16/2012US8288511 Nuclear targeting sequence
10/16/2012US8288510 Isolated peptides having phospholipase inhibitory activity
10/16/2012US8288509 Therapeutic agent for infections, and treatment method using the same
10/16/2012US8288439 Attenuation of reproduction in human cells or transmission of infections ; using polynucleotide
10/16/2012US8288359 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides
10/16/2012US8288352 Auristatins having an aminobenzoic acid unit at the N terminus
10/16/2012US8288351 Antagonists of the bradykinin B1 receptor
10/16/2012US8288350 Methods to prevent and treat diseases
10/16/2012US8288349 Conjugated to antibody; thrombospondin receptor targeting
10/16/2012US8288348 Mixture of cyclosporin A, oil and surfactant; eye diseases
10/16/2012US8288347 Dermal fillers comprising silk fibroin hydrogels and uses thereof
10/16/2012US8288346 Composition and method for the treatment of hyperkalemia
10/16/2012US8288345 Treating stroke and other diseases without inhibiting N-type calcium channels
10/16/2012US8288344 Glass particles in aqueous carrier mixture containing glycerol and polyoxyethylene glycol
10/16/2012US8288343 Activation of endothelial nitric oxide synthase by midkine and uses therefor in effecting vasodilation
10/16/2012US8288341 Control of radiation injury
10/16/2012US8288339 GLP-1 compounds
10/16/2012US8288338 Exendin and exendin agonists for eating disorders
10/16/2012US8288336 Treatment of subarachnoid hemorrhage with ApoE analogs
10/16/2012US8288335 ApoE analogs and methods for their use
10/16/2012US8288334 Peptides for wound healing
10/16/2012US8288126 Methods for making proteins containing free cysteine residues
10/16/2012US8288098 Bioreactive agents
10/16/2012US8287885 GAS57 mutant antigens and GAS57 antibodies
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287882 Flagellin related polypeptides and uses thereof
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/16/2012US8287875 Nucleic acids encoding a house dust mite allergen, Der p III, and uses therefor
10/16/2012US8287874 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287868 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012US8287863 Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
10/16/2012US8287862 Multidrug resistance-associated polypeptide
10/16/2012US8287860 Immunogen and antivenom against violin spider venom
10/16/2012US8287859 Methods of reducing toxicity and effects of cocaine by administering a butyrylcholinesterase (BChE)-albumin fusion protein
10/16/2012US8287858 Proteolytic enzyme formulations
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 3163